# Insight Molecular (IMDX) — Overview

IMDX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/imdx

## Price

Last close $3.06 on Oct 15, 2026. 52-week range $2.55 – $8.48.

## Company profile

Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx. The company geographically operates in the United States, the United Kingdom, Europe, and the Asia-Pacific regions, with maximum revenue generated from the USA.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $1.7M |
| Revenue (quarter) | $239,000.00 |
| Revenue growth (year over year) | -53.86% |
| Gross profit (trailing twelve months) | $807,000.00 |
| Gross margin | 48.32% |
| Net income (trailing twelve months) | −$49.4M |
| Net income (quarter) | −$11.3M |
| Net income growth (year over year) | -15.58% |
| Net margin | -2955.63% |
| Return on equity | 0.00% |
| EPS (trailing twelve months) | −$1.52 |
| Book value per share | −$0.65 |
| P/E (trailing twelve months) | — |
| Price to book | — |
| Debt to assets | 172.34% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Insight Molecular (IMDX) profitable?

No. Insight Molecular reported a net loss of $49.4M over the trailing twelve months.

### How much revenue does Insight Molecular (IMDX) make?

Insight Molecular generated $1.7M in revenue over the trailing twelve months, down 53.86% year over year.

### How do I buy stock in Insight Molecular (IMDX)?

IMDX trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).